Issue 3/2016
Content (19 Articles)
Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancers
Kamaljeet Singh, Umadevi Tantravahi, Michele M. Lomme, Terese Pasquariello, Margaret Steinhoff, C. James Sung
A longitudinal analysis of chronic arm morbidity following breast cancer surgery
Virginia M. Boquiren, Thomas F. Hack, Roanne L. Thomas, Anna Towers, Winkle B. Kwan, Andrea Tilley, Elizabeth Quinlan, Baukje Miedema
Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis
Amila Orucevic, Robert E. Heidel, John L. Bell
Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry
Ralph M. Wirtz, Harri Sihto, Jorma Isola, Päivi Heikkilä, Pirkko-Liisa Kellokumpu-Lehtinen, Päivi Auvinen, Taina Turpeenniemi-Hujanen, Sirkku Jyrkkiö, Sotiris Lakis, Kornelia Schlombs, Mark Laible, Stefan Weber, Sebastian Eidt, Ugur Sahin, Heikki Joensuu
Validation of an oligo-gene signature for the prognostic stratification of ductal carcinoma in situ (DCIS)
Joseph Geradts, Jeffrey Groth, Yuan Wu, Genglin Jin
Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation
Gabriela Szalayova, Aleksandra Ogrodnik, Brianna Spencer, Jacqueline Wade, Janice Bunn, Abiy Ambaye, Ted James, Mercedes Rincon
Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer
Andrew J. Robles, Shengxin Cai, Robert H. Cichewicz, Susan L. Mooberry
Therapeutic inhibition of breast cancer bone metastasis progression and lung colonization: breaking the vicious cycle by targeting α5β1 integrin
Hongren Yao, Donna M. Veine, Donna L. Livant
Great tumour burden in the axilla may influence lymphatic drainage in breast cancer patients
Wenbin Zhou, Yansheng Zhao, Hong Pan, Qin Li, Xiuqing Li, Lin Chen, Xiaoming Zha, Qiang Ding, Cong Wang, Xiaoan Liu, Shui Wang
Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations
R. Lewin, A. Sulkes, T. Shochat, D. Tsoref, S. Rizel, N. Liebermann, D. Hendler, V. Neiman, I. Ben-Aharon, E. Friedman, S. Paluch-Shimon, D. Margel, I. Kedar, R. Yerushalmi
Survival and disease-free benefits with mastectomy versus breast conservation therapy for early breast cancer: a meta-analysis
Yan Chen, Lei Jiang, Bo Gao, Zhi-yuan Cheng, Jiaxin Jin, Ke-hu Yang
A single-center, randomized, parallel controlled study comparing the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer
Yijun Zhou, Tao Ouyang, Yuntao Xie, Tianfeng Wang, Zhaoqing Fan, Yingjian He, Aiping Lu, Yiqiang Liu, Jinfeng Li
Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based study
Inna Y. Gong, Sunil Verma, Andrew T. Yan, Dennis T. Ko, Craig C. Earle, George A. Tomlinson, Maureen E. Trudeau, Murray D. Krahn, Monika K. Krzyzanowska, Christine B. Brezden-Masley, Scott Gavura, Stuart Peacock, Kelvin K. W. Chan
Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer
Lu Chen, Linda S. Cook, Mei-Tzu C. Tang, Peggy L. Porter, Deirdre A. Hill, Charles L. Wiggins, Christopher I. Li
Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy
Ying L. Liu, Anurag Saraf, Shing M. Lee, Xiaobo Zhong, Hanina Hibshoosh, Kevin Kalinsky, Eileen P. Connolly
Long-term consequences of ovarian ablation for premenopausal breast cancer
Janice S. Kwon, Gary Pansegrau, Melica Nourmoussavi, Geoffrey Hammond, Mark S. Carey
Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources
Tomi Akinyemiju, Justin Xavier Moore, Akinyemi I. Ojesina, John W. Waterbor, Sean F. Altekruse
Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis
Antonio Di Meglio, Rachel A. Freedman, Nancy U. Lin, William T. Barry, Otto Metzger-Filho, Nancy L. Keating, Tari A. King, Mario Roberto Sertoli, Francesco Boccardo, Eric P. Winer, Ines Vaz-Luis
Associations between metabolic syndrome, breast cancer recurrence, and the 21-gene recurrence score assay
Jeanette Muniz, Kelley M. Kidwell, N. Lynn Henry